Transcranial Static Magnetic Stimulation (tSMS) in Huntington's Disease (HD)

Inclusion Criteria: * Diagnosis of HD genetically confirmed (number of CAG triplets ≥36) * Presence of chorea movements quantified with a score ≥ 10 on the sum of the scores of the subscale of the Unified Huntington's Disease Rating Scale (UHDRS) for the evaluation of maximum chorea for the facial, oro-bucco-lingual, truncal, four limbs districts * Ability to provide written informed consent * No changes in drug therapy in the 8 weeks prior to the baseline visit * No changes in drug therapy for the entire duration of the study Exclusion Criteria: * Contraindications to exposure to magnetic fields * Patients who are pregnant or breastfeeding * Presence of significant risk of suicidal behavior * Patients who have received an investigational drug in a clinical trial within 30 days of the baseline visit or have planned to use such an investigational drug during the study